Abiopharma

New Form 8-K - enGene Holdings Inc. Filed: 2025-09-03 AccNo: 0000950170-25-112674 Size: 1 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits